T2510
Galunisertib
TargetMol
DESCRIPTION
Galunisertib (LY2157299) is an orally available inhibitor of TGFβRI kinase (IC50: 56 nM) with potential antineoplastic activity.
DETAILS
- Cas: 700874-72-2
- Purity: 99.98%
- Smiles: CC1=NC(C=2C(=C3N(N2)CCC3)C=4C5=C(C=CC(C(N)=O)=C5)N=CC4)=CC=C1
- Category: Compound
- Molecular Weight: 369.42
- Molecular Formula: C22H19N5O
Lead Time: 4 - 5 weeks
Sign in to view pricing